Carboplatin Alternatives Compared
| Carboplatin | Avastin | Lynparza |
|
|---|
| Carboplatin | Avastin (bevacizumab) | Lynparza (olaparib) |
|
|||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Ovarian Cancer, Cancer, Cervical Cancer. carboplatin may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Colorectal Cancer, Glioblastoma Multiforme, Cervical Cancer, Fallopian Tube Cancer, Hepatocellular Carcinoma, Non Small Cell Lung Cancer, Ovarian Cancer, Peritoneal Cancer, Renal Cell... View more |
Prescription only
Prescribed for Ovarian Cancer, Prostate Cancer, Breast Cancer, Pancreatic Cancer, Breast Cancer - Metastatic. Lynparza may also be used for purposes not listed in this medication guide. |
Related suggestions Ovarian Cancer
|
|||||||||||||||||||||||
| More about Carboplatin | More about Avastin (bevacizumab) | More about Lynparza (olaparib) | ||||||||||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||||||||||
|
Carboplatin has an average rating of 7.3 out of 10 from a total of 5 ratings on Drugs.com. 75% of reviewers reported a positive effect, while 25% reported a negative effect. |
Avastin has an average rating of 7.7 out of 10 from a total of 30 ratings on Drugs.com. 69% of reviewers reported a positive effect, while 12% reported a negative effect. |
Lynparza has an average rating of 7.2 out of 10 from a total of 17 ratings on Drugs.com. 73% of reviewers reported a positive effect, while 27% reported a negative effect. |
||||||||||||||||||||||||
| Drug Class | ||||||||||||||||||||||||||
| Side Effects | ||||||||||||||||||||||||||
|
See also: carboplatin side effects in more detail. |
See also: Avastin side effects in more detail. |
See also: Lynparza side effects in more detail. |
||||||||||||||||||||||||
| Generic Availability | ||||||||||||||||||||||||||
|
Lower cost generic |
N/A |
|||||||||||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all carboplatin prices |
View all Avastin prices |
View all Lynparza prices |
||||||||||||||||||||||||
| Dosage Forms Available | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
| Brand Names | ||||||||||||||||||||||||||
| Carboplatin Novaplus | Other bevacizumab brands include: Alymsys, Avzivi, Mvasi, Vegzelma, Zirabev |
N/A |
||||||||||||||||||||||||
| Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||||||||||
|
120 hours |
480 hours |
11.9 hours |
||||||||||||||||||||||||
| CSA Schedule ** View glossary of terms | ||||||||||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
| Pregnancy Category | ||||||||||||||||||||||||||
|
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
||||||||||||||||||||||||
| Drug Interactions | ||||||||||||||||||||||||||
|
A total of 344 drugs are known to interact with carboplatin:
|
A total of 47 drugs are known to interact with Avastin:
|
A total of 582 drugs are known to interact with Lynparza:
|
||||||||||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
||||||||||||||||||||||||
| Disease Interactions | ||||||||||||||||||||||||||
| First Approval Date | ||||||||||||||||||||||||||
|
N/A |
February 26, 2004 |
December 19, 2014 |
||||||||||||||||||||||||
| WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||||||||||
| More Information | ||||||||||||||||||||||||||
| Patient resources | ||||||||||||||||||||||||||
| Professional Resources | ||||||||||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.